Copyright
©The Author(s) 2017.
World J Gastroenterol. Apr 21, 2017; 23(15): 2771-2784
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2771
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2771
Figure 6 S-plots following (A) PCA, (B) PLS, and (C) OPLS analyses with (A1, B1, C1) electrospray ionization (ESI+) and without (A2, B2, C2) electrospray ionization (ESI-) in the non-alcoholic steatohepatitis and control groups.
PCA: Principal component analysis; NASH: Non-alcoholic steatohepatitis.
- Citation: Dong S, Zhan ZY, Cao HY, Wu C, Bian YQ, Li JY, Cheng GH, Liu P, Sun MY. Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease. World J Gastroenterol 2017; 23(15): 2771-2784
- URL: https://www.wjgnet.com/1007-9327/full/v23/i15/2771.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i15.2771